Sr One Capital Management
Latest statistics and disclosures from Sr One Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ACLX, SPRY, DSGN, MLYS, NKTX, and represent 100.00% of Sr One Capital Management's stock portfolio.
- Reduced shares in these 2 stocks: ACLX (-$44M), Effector Therapeutics.
- Sold out of its position in Effector Therapeutics.
- Sr One Capital Management was a net seller of stock by $-48M.
- Sr One Capital Management has $238M in assets under management (AUM), dropping by 22.06%.
- Central Index Key (CIK): 0001910264
Tip: Access up to 7 years of quarterly data
Positions held by Sr One Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sr One Capital Management
Sr One Capital Management holds 5 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 73.3 | $175M | -20% | 3.1M | 55.50 |
|
| Silverback Therapeutics (SPRY) | 9.2 | $22M | 4.0M | 5.48 |
|
|
| Design Therapeutics (DSGN) | 7.3 | $17M | 6.5M | 2.65 |
|
|
| Mineralys Therapeutics (MLYS) | 6.5 | $15M | 1.8M | 8.60 |
|
|
| Nkarta (NKTX) | 3.7 | $8.8M | 1.3M | 6.60 |
|
Past Filings by Sr One Capital Management
SEC 13F filings are viewable for Sr One Capital Management going back to 2021
- Sr One Capital Management 2023 Q4 filed Feb. 12, 2024
- Sr One Capital Management 2023 Q3 filed Nov. 13, 2023
- Sr One Capital Management 2023 Q2 filed Aug. 10, 2023
- Sr One Capital Management 2023 Q1 restated filed May 19, 2023
- Sr One Capital Management 2023 Q1 filed May 9, 2023
- Sr One Capital Management 2022 Q4 filed Feb. 8, 2023
- Sr One Capital Management 2022 Q3 filed Nov. 8, 2022
- Sr One Capital Management 2022 Q2 filed Aug. 2, 2022
- Sr One Capital Management 2022 Q1 filed May 10, 2022
- Sr One Capital Management 2021 Q4 filed Feb. 14, 2022